High-throughput virtual screening of phenylpyrimidine derivatives as selective JAK3 antagonists using computational methods
Journal of Biomolecular Structure and Dynamics,
Journal Year:
2023,
Volume and Issue:
42(14), P. 7574 - 7599
Published: Aug. 4, 2023
In
this
study,
we
used
phenylpyrimidine
derivatives
with
known
biological
activity
against
JAK3,
a
critical
tyrosine
kinase
enzyme
involved
in
signaling
pathways,
to
find
similar
compounds
as
potential
treatments
for
rheumatoid
arthritis.
These
inhibitors
inhibited
JAK3
by
forming
covalent
bond
the
Cys909
residue,
which
resulted
strong
inhibitory
effect.
Phenylpyrimidine
is
considered
promising
therapeutic
target.
For
pharmacophore
modeling,
39
high
pIC50
(Exp)
values
were
chosen.
The
best
model
produced
28
molecules,
and
five-point
common
hypothesis
from
P
HASE
(DHRRR_1)
revealed
requirement
hydrogen
donor
feature,
hydrophobic
group
three
aromatic
ring
features
further
design.
validation
of
phase
was
performed
through
3D-QSAR
using
partial
least
squares
(P
LS).
study
two
successful
models,
an
atom-based
(R2
=
0.95;
Q2
0.67)
field-based
0.93;
0.76),
predict
new
compounds.
successfully
distinguished
between
active
inactive
medications,
discovered
inhibitors,
demonstrated
validity
ROC
0.
77.
ADME-Tox
eliminate
that
might
have
adverse
effects.
pharmacokinetics
affinity
selected
docking.
A
molecular
dynamics
simulation
molecules
protein
complex
confirm
stability
interaction
whereas
MM/GBSA
simulations
confirmed
their
binding
affinity.
By
principle
retrosynthesis,
able
map
out
pathway
synthesizing
these
drug
candidates.
This
has
offer
valuable
practical
insights
optimizing
novel
phenylpyrimidine.Communicated
Ramaswamy
H.
Sarma.
Language: Английский
Naringenin-4'-glucuronide as a new drug candidate against the COVID-19 Omicron variant: a study based on molecular docking, molecular dynamics, MM/PBSA and MM/GBSA
Journal of Biomolecular Structure and Dynamics,
Journal Year:
2023,
Volume and Issue:
42(11), P. 5881 - 5894
Published: July 2, 2023
This
study
aimed
to
identify
natural
bioactive
compounds
(NBCs)
as
potential
inhibitors
of
the
spike
(S1)
receptor
binding
domain
(RBD)
COVID-19
Omicron
variant
using
computer
simulations
(
Language: Английский
Network pharmacology and an in silico-based study to identify proinflammatory pathways and promising bioactive polyphenols for the treatment of sickle cell anemia
Lila Rosa Maturana Pérez,
No information about this author
Johana Márquez Lázaro,
No information about this author
Neyder Contreras Puentes
No information about this author
et al.
Research Square (Research Square),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Jan. 30, 2024
Abstract
Sickle
cell
anemia
(SCA)
is
a
disease
transmitted
as
an
autosomal
recessive
Mendelian
trait.
It
causes
symptoms
that
worsen
with
age,
such
acute
and
chronic
pain,
chest
syndrome,
pulmonary
hypertension,
stroke,
kidney
disease,
vaso-occlusive
crises
(VOCs),
which
are
the
leading
cause
of
hospitalization
premature
death.
Although
there
existing
treatments
to
manage
it,
side
effects
related
VOCs
patients’
inflammatory
state
requires
review
options
for
its
control.
In
this
sense,
study
polyphenols
represents
potential
alternative
treatment
ACS
due
their
widely
reported
anti-inflammatory
capacities.
This
research
identified
hub
genes
associated
processes
in
SCA
by
extracting
differentially
expressed
(DEGs)
GEO
dataset
collection.
Then,
activity
were
selected
from
natural
product
databases,
subsequently,
molecular
docking
was
performed
key
protein
derived
genes.
Finally,
dynamics
on
promising
complexes.
The
comparative
analysis
allowed
us
find
10
proinflammatory
pathways
(MX1,
FIT1,
IFIT3,
STAT1,
ISG15,
GBP1,
OAS1,
OAS2,
OAS3,
RSAD);
among
them,
STAT1
central
gene
regulating
expression
rest.
Docking
studies
showed
good
binding
energies
fifteen
polyphenolic
extracted
compounds,
quercetin,
diosmetin,
fisetin
showing
lowest
energies.
These
flavonoids
have
been
described
past
compounds
having
antioxidant
features,
well
possible
alternatives
treatment.
Language: Английский
Identification of proinflammatory pathways and promising bioactive polyphenols for the treatment of sickle cell anemia by in silico study and network pharmacology
Lila Rosa Maturana Pérez,
No information about this author
Johana Márquez Lázaro,
No information about this author
Neyder Contreras Puentes
No information about this author
et al.
Published: Feb. 22, 2024
Abstract
Sickle
cell
anemia
(SCA)
is
an
autosomal
recessive
Mendelian
trait
characterized
by
symptoms
that
include
acute
and
chronic
pain,
chest
syndrome,
pulmonary
hypertension,
stroke,
kidney
disease,
vaso-occlusive
crises
(VOCs),
all
of
which
worsen
with
age;
VOCs
are
the
leading
cause
hospitalization
premature
death
in
SCA
patients.
Currently,
despite
existence
treatments
for
SCA,
negative
consequences
VOCs’
inflammatory
state
demand
exploration
alternative
methods
control.
For
this
reason,
goal
research
was
to
find
novel
pathways
promising
bioactive
polyphenols
treatment
using
a
combination
network
pharmacology
silico
approaches;
due
polyphenols,
they
have
shown
widely
reported
anti-inflammatory
properties.
Initially,
hub
genes
associated
processes
were
identified
extracting
differentially
expressed
(DEGs)
from
publicly
available
GEO
dataset
(GSE53441),
followed
their
validation
through
system
biology
analysis,
Polyphenols
activity
selected
natural
product
databases;
finally,
molecular
docking
dynamics
performed
key
protein
derived
genes.
As
result,
10
Type
I
interferon
(IFN-I)
pathway
(MX1,
FIT1,
IFIT3,
STAT1,
ISG15,
GBP1,
OAS1,
OAS2,
OAS3,
RSAD);
among
them,
STAT1
as
central
gene
regulating
expression
rest.
Docking
studies
showed
good
binding
energies
fifteen
polyphenolic
extracted
compounds,
quercetin,
diosmetin,
fisetin
showing
lowest
energies.
Identified
flavonoids
been
described
past
compounds
having
antioxidant
features,
well
possible
alternatives
treatment.
Language: Английский
Identification of proinflammatory pathways and promising bioactive polyphenols for the treatment of sickle cell anemia by in silico study and network pharmacology
Informatics in Medicine Unlocked,
Journal Year:
2024,
Volume and Issue:
49, P. 101534 - 101534
Published: Jan. 1, 2024
Sickle
cell
anemia
(SCA)
is
an
autosomal
recessive
Mendelian
trait
characterized
by
symptoms
that
include
acute
and
chronic
pain,
chest
syndrome,
pulmonary
hypertension,
stroke,
kidney
disease,
vaso-occlusive
crises
(VOCs),
all
of
which
worsen
with
age;
VOCs
are
the
leading
cause
hospitalization
premature
death
in
SCA
patients.
Currently,
despite
existence
treatments
for
SCA,
negative
consequences
VOCs'
inflammatory
state
demand
exploration
alternative
methods
control.
For
this
reason,
goal
research
was
to
find
novel
pathways
promising
bioactive
polyphenols
treatment
using
a
combination
network
pharmacology
silico
approaches;
due
polyphenols,
they
have
shown
widely
reported
anti-inflammatory
properties.
Initially,
hub
genes
associated
processes
were
identified
extracting
differentially
expressed
(DEGs)
from
publicly
available
GEO
dataset
(GSE53441),
followed
their
validation
through
system
biology
analysis,
Polyphenols
activity
selected
natural
product
databases;
finally,
molecular
docking
dynamics
performed
key
protein
derived
genes.
As
result,
10
Type
I
interferon
(IFN-I)
pathway
(MX1,
FIT1,
IFIT3,
STAT1,
ISG15,
GBP1,
OAS1,
OAS2,
OAS3,
RSAD);
among
them,
STAT1
as
central
gene
regulating
expression
rest.
Docking
studies
showed
good
binding
energies
fifteen
polyphenolic
extracted
compounds,
quercetin,
diosmetin,
fisetin
showing
lowest
energies.
Identified
flavonoids
been
described
past
compounds
having
antioxidant
features,
well
possible
alternatives
treatment.
Language: Английский
Eugenol Biobased Polydiacetylene
Crystal Growth & Design,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 1, 2024
Language: Английский
Exploring the Potential of Supercritical Carbon Dioxide for Eugenol Impregnation in 3D Printed Polylactic Acid Structures
Janet de los Angeles Chinellato Díaz,
No information about this author
Marcelo R. Romero,
No information about this author
María L. Goñi
No information about this author
et al.
The Journal of Supercritical Fluids,
Journal Year:
2024,
Volume and Issue:
unknown, P. 106469 - 106469
Published: Nov. 1, 2024
Language: Английский
COVID-19 in Dental Practice Is Prevented by Eugenol Responsible for the Ambient Odor Specific to Dental Offices: Possibility and Speculation
Hironori Tsuchiya,
No information about this author
Yoshiaki Takai
No information about this author
Medical Principles and Practice,
Journal Year:
2023,
Volume and Issue:
33(2), P. 83 - 89
Published: Dec. 26, 2023
Dental
professionals
routinely
work
in
proximity
to
patients
even
when
either
or
both
of
them
have
suspected
confirmed
COVID-19.
The
oral
cavity
also
serves
as
a
reservoir
for
SARS-CoV-2
because
the
virus
is
present
and
replicates
secretions
(saliva
gingival
crevicular
fluid),
tissues
(salivary
gland
periodontal
tissue),
microenvironments
(gingival
sulcus
pocket).
Despite
high
risk
infection,
prevalence
COVID-19
dentists,
dental
hygienists,
assistants,
their
was
similar
that
general
population
during
pandemic.
We
propose
eugenol,
which
responsible
ambient
odor
specific
offices,
could
contribute
prevention
settings.
Eugenol
not
only
released
from
materials
(filling,
cement,
sealer)
but
aerosolized
by
procedures
(grinding,
polishing,
restoration).
Such
eugenol
has
been
suggested
possess
potential
inhibit
infectivity
replication
SARS-CoV-2,
entry
into
human
cells
binding
specifically
viral
spike
protein,
protease
indispensable
replication.
It
shown
acts
on
airborne
viruses
reduce
loads.
This
review
highlights
hypothesis
environment
offices
impregnated
with
suppresses
transmission
contagion
between
patients,
preventing
practice.
Anti-COVID-19
might
give
insights
safe
delivery
treatment
care
era.
Language: Английский